Watchtower Advisors, LP
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 14, 2026), Watchtower Advisors, LP reported 12 stock positions worth $141.0 million. Its top holding was ASML Holding NV-NY Reg SHS (ASML) at 29.3% of the portfolio, followed by Omega Healthcare Investors (OHI, 16.8%) and Patrick Industries (PATK, 11.8%). Compared with Q4 2025, it opened 3 new positions, sold out of 2, added to 2 and reduced 4. The biggest buy was Omega Healthcare Investors (OHI, shares +60%) and the biggest sale CVS Health (CVS, shares −49%).
- Most Recent 13F
- Q2 2026
- Location
- OLD GREENWICH, CT
- CIK
- 0001807092
- Portfolio Value
- $141.0M (Q1 2026)
- SEC Filing
- 0001807092-26-000007 ↗ filed May 14, 2026
Holdings Value
Holdings 12 stocks · $141.0M
| ASML ASML Holding NV-NY Reg SHS filed as ASML HLDG NV | 29.29% | 31,261 | $41.3M | No change |
| OHI Omega Healthcare Investors | 16.82% | 541,138 | $23.7M | Add +59.6% |
| PATK Patrick Industries Inc. | 11.82% | 150,000 | $16.7M | No change |
| CVS CVS Health Corp. | 9.29% | 182,357 | $13.1M | Reduce -48.9% |
| SGI Somnigroup International Inc. | 7.33% | 139,866 | $10.3M | Add +37.9% |
| IBP Installed Building Products | 6.07% | 32,277 | $8.6M | No change |
| AMD Advanced Micro Devices | 5.77% | 40,000 | $8.1M | Reduce -33.3% |
| MU Micron Technology Inc. | 5.52% | 23,047 | $7.8M | New |
| ELAN Elanco Animal Health Inc. | 2.51% | 147,816 | $3.5M | New |
| AVGO Broadcom Inc. | 2.47% | 11,235 | $3.5M | Reduce -62.5% |
| SRE Sempra | 2.46% | 35,666 | $3.5M | New |
| APH Amphenol Corp. Class A | 0.66% | 7,378 | $932K | Reduce -92.6% |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $179.6M | ASML, OHI, CVS, MU, PATK |
| Q1 2026 | 12 | $141.0M | ASML, OHI, PATK, CVS, SGI |
| Q4 2025 | 11 | $165.6M | ASML, CVS, PATK, OHI, APH |
| Q3 2025 | 16 | $214.3M | CVS, ASML, RCL, CLH, APH |
| Q2 2025 | 18 | $168.9M | AXS, CVS, RCL, APPF, APH |
| Q1 2025 | 15 | $137.8M | AXS, CVS, HLT, RCL, VRNA |
| Q4 2024 | 14 | $176.7M | AXS, FTAI, HLT, ALLE, AVGO |
| Q3 2024 | 15 | $215.7M | AVGO, ACGL, HLT, AXS, FTAI |
| Q2 2024 | 11 | $155.1M | AVGO, ACGL, AXS, LII, MEDP |
| Q1 2024 | 13 | $180.2M | AVGO, LII, ACGL, MEDP, SPR |